JNJ-0387
- Generic Name
- JNJ-0387
A Study of JNJ-87890387 for Advanced Solid Tumors
- First Posted Date
- 2023-12-21
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 158
- Registration Number
- NCT06178614
- Locations
- 🇪🇸
Hosp Univ Vall D Hebron, Barcelona, Spain
🇺🇸Start Midwest, Grand Rapids, Michigan, United States
🇫🇷Centre Leon Berard, Lyon, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath